Literature DB >> 10998676

Therapy of Migraine Headache in Cancer Patients.

.   

Abstract

This article reviews how to establish the diagnosis of migraine, the possible differential diagnoses, and the present state of the art of therapy. Emphasis is laid on nonsteroidal antiphlogistic drugs, serotonin receptor agonists (the so called triptans), and antiemetic drugs. The interval therapy consists of beta-blockers, calcium antagonists, antiepileptics, and serotonin receptor antagonists. The pathophysiology is based on the concept of sterile neurogenic inflammation, cortical spreading depression (CSD), and hyperexcitability of the central nervous system (CNS).

Entities:  

Year:  1999        PMID: 10998676     DOI: 10.1007/s11916-999-0015-z

Source DB:  PubMed          Journal:  Curr Rev Pain        ISSN: 1069-5850


  58 in total

1.  Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat.

Authors:  H Kaube; K L Hoskin; P J Goadsby
Journal:  Cephalalgia       Date:  1992-06       Impact factor: 6.292

Review 2.  Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists.

Authors:  G Emilien; J M Maloteaux
Journal:  Eur J Clin Pharmacol       Date:  1998-02       Impact factor: 2.953

3.  Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.

Authors:  J Schoenen; J Jacquy; M Lenaerts
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

Review 4.  Mitochondria, magnesium and migraine.

Authors:  K M Welch; N M Ramadan
Journal:  J Neurol Sci       Date:  1995-12       Impact factor: 3.181

5.  Extracellular ionic variations during spreading depression.

Authors:  R P Kraig; C Nicholson
Journal:  Neuroscience       Date:  1978       Impact factor: 3.590

6.  Perfusion-weighted imaging defects during spontaneous migrainous aura.

Authors:  F M Cutrer; A G Sorensen; R M Weisskoff; L Ostergaard; M Sanchez del Rio; E J Lee; B R Rosen; M A Moskowitz
Journal:  Ann Neurol       Date:  1998-01       Impact factor: 10.422

Review 7.  Comprehensive management of headache and depression.

Authors:  S D Silberstein
Journal:  Cephalalgia       Date:  1998-02       Impact factor: 6.292

8.  Domperidone plus paracetamol in the treatment of migraine.

Authors:  E A MacGregor; M Wilkinson; K Bancroft
Journal:  Cephalalgia       Date:  1993-04       Impact factor: 6.292

Review 9.  Neurogenic inflammation in the pathophysiology and treatment of migraine.

Authors:  M A Moskowitz
Journal:  Neurology       Date:  1993-06       Impact factor: 9.910

10.  The neurobiology of vascular head pain.

Authors:  M A Moskowitz
Journal:  Ann Neurol       Date:  1984-08       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.